Whitehawk Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Morristown, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
23
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Whitehawk Therapeutics Inc. market cap is $180.57M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Whitehawk Therapeutics Inc. 52 week high is $5.50 as of November 17, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Whitehawk Therapeutics Inc. 52 week low is $1.97 as of November 17, 2026.
Whitehawk Therapeutics Inc. stock price today is $3.01.
Whitehawk Therapeutics Inc. stock price yesterday was $3.06.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Whitehawk Therapeutics Inc.'s P/E ratio is -2.78.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Whitehawk Therapeutics Inc. P/B ratio is 1.0886.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Whitehawk Therapeutics Inc. 50-day moving average is $3.50.